Zhanfang Kang

Title: Zhanfang Kang: Innovator in Estrogen-Related Receptor Modulators

Introduction

Zhanfang Kang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate estrogen-related receptors. His work has implications for treating various metabolic diseases.

Latest Patents

Zhanfang Kang holds a patent for "Compounds of estrogen-related receptor modulators and the uses thereof." This patent includes compounds defined by a specific formula, their pharmaceutically acceptable acid or base addition salts, and their applications in preparing medicaments. These compounds can be utilized for modulating estrogen-related receptors (ERR) and treating metabolic diseases such as high blood fat, fatty liver, hyperglycemia, diabetes, and obesity. The substituents of the formula are detailed in the patent description.

Career Highlights

Zhanfang Kang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has led to advancements in understanding how estrogen-related receptors can be targeted for therapeutic purposes.

Collaborations

Zhanfang Kang has collaborated with notable colleagues, including Lijie Peng and Chiwai Wong. Their joint efforts contribute to the ongoing research in the field of receptor modulators.

Conclusion

Zhanfang Kang's innovative work in estrogen-related receptor modulators showcases his commitment to advancing medical science. His contributions are vital for developing new treatments for metabolic diseases, highlighting the importance of research in this area.